Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KRN125 for Stem Cell Mobilization in Healthy Volunteers
NCT03993639Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- May 2019
- Primary completion
- Jul 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegfilgrastim in hematopoietic stem cell mobilization, sponsored by Kyowa Kirin. Started May 2019; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
hematopoietic stem cell mobilization
Beyond the preview
Go deeper on NCT03993639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03993639.